BlackRock’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,074
| Closed | -$1.35K | – | 5563 |
|
|
2025
Q3 | $1.35K | Hold |
7,074
| – | – | ﹤0.01% | 5335 |
|
|
2025
Q2 | $12K | Hold |
7,074
| – | – | ﹤0.01% | 5201 |
|
|
2025
Q1 | $11.2K | Hold |
7,074
| – | – | ﹤0.01% | 5167 |
|
|
2024
Q4 | $12.7K | Buy |
7,074
+1,465
| +26% | +$4.67K | ﹤0.01% | 5158 |
|
|
2024
Q3 | $34K | Hold |
5,609
| – | – | ﹤0.01% | 4878 |
|
|
2024
Q2 | $29.5K | Hold |
5,609
| – | – | ﹤0.01% | 4950 |
|
|
2024
Q1 | $47.6K | Sell |
5,609
-2,068
| -27% | -$18.1K | ﹤0.01% | 4880 |
|
|
2023
Q4 | $50.7K | Hold |
7,677
| – | – | ﹤0.01% | 4965 |
|
|
2023
Q3 | $23.7K | Buy |
7,677
+5,416
| +240% | +$15.6K | ﹤0.01% | 5123 |
|
|
2023
Q2 | $6.11K | Hold |
2,261
| – | – | ﹤0.01% | 5293 |
|
|
2023
Q1 | $6.71K | Buy |
+2,261
| New | +$6.64K | ﹤0.01% | 5350 |
|
|
2022
Q2 | – | Sell |
-85,069
| Closed | -$525K | – | 5881 |
|
|
2022
Q1 | $525K | Sell |
85,069
-569
| -0.7% | -$5K | ﹤0.01% | 4854 |
|
|
2021
Q4 | $1.22M | Buy |
85,638
+4,000
| +5% | +$44.6K | ﹤0.01% | 4603 |
|
|
2021
Q3 | $653K | Buy |
81,638
+15,251
| +23% | +$242K | ﹤0.01% | 4683 |
|
|
2021
Q2 | $1.9M | Buy |
+66,387
| New | +$1.93M | ﹤0.01% | 4294 |
|
|
2021
Q1 | – | Sell |
-3,755
| Closed | -$45K | – | 5291 |
|
|
2020
Q4 | $45K | Hold |
3,755
| – | – | ﹤0.01% | 4687 |
|
|
2020
Q3 | $26K | Buy |
3,755
+1,630
| +77% | +$11.1K | ﹤0.01% | 4679 |
|
|
2020
Q2 | $13K | Buy |
+2,125
| New | +$10.1K | ﹤0.01% | 4749 |
|
BlackRock's EPIX Position: Q4 2025 in Review
BlackRock sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 7,074 shares — an estimated $1.35K sold.
BlackRock first reported a position in EPIX in Q2 2020 and held it in 18 quarters. The position peaked at $1.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- BlackRock reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- BlackRock sold 7,074 ESSA Pharma shares in Q4 2025, an estimated $1.35K.
- BlackRock first reported a position in ESSA Pharma in Q2 2020 and held it in 18 quarters.
- BlackRock's ESSA Pharma position peaked at $1.9M in Q2 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.